Bambusa Aesculus
FDA Label NDC 48951-2003

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Uriel Pharmacy Inc. for the product Bambusa Aesculus (NDC 48951-2003). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding indications & usage, dosage & administration, otc - active ingredient, inactive ingredient, otc - purpose, otc - keep out of reach of children, warnings, otc - questions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Indications & Usage

Directions:  Under age 2: Consult a doctor.

Dosage & Administration

Apply gel to skin as needed.

Otc - Active Ingredient

Active Ingredients: Bambusa (Bamboo) 6X, Betonica (Wood betony) 6X, Rosmarinus (Rosemary) 6X, Formica (Red wood ant) 7X, Disci intervert. (Bovine intervertebral discs of the cervical, thoracic and lumbar spine) 8X, Jasper 12X, Arnica 20X, Aesculus (Horse chestnut seed) 50X

Inactive Ingredient

Inactive Ingredients: Distilled water, Glycerin, Sodium alginate, Lavender oil, Rosemary oil, Potassium sorbate, Grapefruit seed extract

Otc - Purpose

Use: Temporary relief of headache.

Otc - Keep Out Of Reach Of Children

KEEP OUT OF REACH OF CHILDREN.

Warnings

Warnings: FOR EXTERNAL USE ONLY.
Do not use if allergic to any ingredient. Consult a doctor before use for serious conditions, if conditions worsen or persist, or accidental ingestion occurs. If pregnant or nursing, consult a doctor before use. Do not use if safety seal is broken or missing. Avoid contact with eyes. Natural ingredients may cause color and/or scent variation.

Otc - Questions

Questions? Call 866.642.2858
Made with care by Uriel, East Troy, WI 53120
www.urielpharmacy.com

Package Label.Principal Display Panel

* Please review the disclaimer below.